Startup DreamersStartup Dreamers
  • Home
  • Startup
  • Money & Finance
  • Starting a Business
    • Branding
    • Business Ideas
    • Business Models
    • Business Plans
    • Fundraising
  • Growing a Business
  • More
    • Innovation
    • Leadership
Trending

This City Is the Best Place to Be an Entrepreneur Right Now

July 6, 2025

Airplane Wi-Fi Is Now … Good?

July 6, 2025

Today’s ‘Wordle’ #1477 Hints, Clues And Answer For Friday, July 4th

July 5, 2025
Facebook Twitter Instagram
  • Newsletter
  • Submit Articles
  • Privacy
  • Advertise
  • Contact
Facebook Twitter Instagram
Startup DreamersStartup Dreamers
  • Home
  • Startup
  • Money & Finance
  • Starting a Business
    • Branding
    • Business Ideas
    • Business Models
    • Business Plans
    • Fundraising
  • Growing a Business
  • More
    • Innovation
    • Leadership
Subscribe for Alerts
Startup DreamersStartup Dreamers
Home » RSV Cases Are Surging, But New Tools Available To Fight The Virus
Innovation

RSV Cases Are Surging, But New Tools Available To Fight The Virus

adminBy adminSeptember 7, 20230 ViewsNo Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email

As Covid-19 cases rise in many parts of the country, another virus is also surging. Respiratory syncytial virus, or RSV, is causing an increased number of emergency department visits and hospitalizations in Florida and other southeastern states, and will likely begin to impact the rest of the nation in the coming weeks. The spike in RSV cases prompted the Centers for Disease Control and Prevention (CDC) to issue a health alert this week, recommending clinicians and caregivers be on the lookout for patients with symptoms suggestive of RSV.

What Is Respiratory Syncytial Virus?

RSV is an RNA virus that was first discovered in the 1950s, and has long been recognized as a significant cause of respiratory illness in young children. In fact, RSV is the most common cause of bronchiolitis (i.e., inflammation of the small passages in the lungs) among children less than one year of age, and results in nearly 60,000 children being hospitalized in the United States each year. Worldwide, it’s estimated to infect 64 million people and cause 160,000 deaths annually.

In most cases, symptoms are generally mild and include a runny nose, cough, mild headache and mild fever. However, in young children, the elderly and those who are immunocompromised, symptoms can be severe and involve wheezing, a significant cough and respiratory distress.

What Can Be Done To Treat Or Prevent Disease?

Similar to Covid-19, RSV is typically spread through respiratory droplets that are produced when an infected person coughs or sneezes. For years, the best means of protection from RSV was good hand hygiene, as well as covering your mouth or nose when coughing and sneezing. During the Covid-19 pandemic, the rates of RSV plummeted, likely due to a combination of factors, including social distancing, masking and reduced travel. However, as pandemic precautions have lifted, the incidence of RSV has increased and will likely return to a typical seasonal pattern, where cases surge in the fall and winter months in the norther hemisphere. Fortunately, in 2023, several new tools have been approved by the Food and Drug Administration (FDA) to prevent severe disease resulting from RSV infection.

The first is a monoclonal antibody, called nirsevimab, which is given by intramuscular infection and is recommended by the CDC for all infants less than eight months of age. The immunization is also recommended for children eight to 19 months of age who are immunocompromised or at risk for severe disease. Clinical trials showed nirsevimab to provide protection for at least 5 months and reduce the incidence of hospitalization and healthcare visits among infected infants by 80%.

Several new RSV vaccines have also received FDA approval. For adults 60 years of age and older, two recombinant protein vaccines (RSVPreF3 and RSVpreF) are now available and have been shown to be more than 80% effective in preventing lower respiratory disease. On August 21, 2023, RSVpreF was approved by the FDA for pregnant women during weeks 32 through 36 of gestation. Infants born to vaccinated mothers demonstrated significant rates of protection from severe, lower respiratory tract disease for at least 6 months following birth.

These new tools represent a revolutionary advancement in our fight against a virus that has historically killed nearly 15,000 people each year in the United States.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Today’s ‘Wordle’ #1477 Hints, Clues And Answer For Friday, July 4th

Innovation July 5, 2025

UFC Veteran Announces Retirement 2 Days Before Her 30th Birthday

Innovation July 4, 2025

Today’s NYT Mini Crossword Clues And Answers For Thursday, July 3

Innovation July 3, 2025

Today’s NYT Mini Crossword Answers For Wednesday, July 2

Innovation July 2, 2025

AI Investor Stuck At A Standstill? 3 Strategic Paths To Buy, Build, Or Partner With AI Vendors

Innovation July 1, 2025

First Pill For Obstructive Sleep Apnea Shows Promise In Phase 3 Study

Innovation June 30, 2025
Add A Comment

Leave A Reply Cancel Reply

Editors Picks

This City Is the Best Place to Be an Entrepreneur Right Now

July 6, 2025

Airplane Wi-Fi Is Now … Good?

July 6, 2025

Today’s ‘Wordle’ #1477 Hints, Clues And Answer For Friday, July 4th

July 5, 2025

This Mistake Can Tank a Deal, Even If Your Business Is Solid

July 5, 2025

Why Storytelling (Not Selling) Is Your Most Powerful Branding Tool

July 5, 2025

Latest Posts

eBay and Vestiaire Collective Want an Exemption from Trump’s Tariffs

July 5, 2025

UFC Veteran Announces Retirement 2 Days Before Her 30th Birthday

July 4, 2025

How an Accident at Age 18 Led to a Business With $35M Sales

July 4, 2025

Venice Braces for Jeff Bezos and Lauren Sanchez’s Wedding

July 4, 2025

Today’s NYT Mini Crossword Clues And Answers For Thursday, July 3

July 3, 2025
Advertisement
Demo

Startup Dreamers is your one-stop website for the latest news and updates about how to start a business, follow us now to get the news that matters to you.

Facebook Twitter Instagram Pinterest YouTube
Sections
  • Growing a Business
  • Innovation
  • Leadership
  • Money & Finance
  • Starting a Business
Trending Topics
  • Branding
  • Business Ideas
  • Business Models
  • Business Plans
  • Fundraising

Subscribe to Updates

Get the latest business and startup news and updates directly to your inbox.

© 2025 Startup Dreamers. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

GET $5000 NO CREDIT